RecruitingPhase 2NCT06568198

Modulation Effect of tACS on Chronic Low Back Pain

Modulation Effect of Transcranial Alternating Current Stimulation (tACS) on Chronic Low Back Pain


Sponsor

Massachusetts General Hospital

Enrollment

80 participants

Start Date

Aug 25, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Investigating the modulation effect of tACS


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria5

  • Volunteers 18-60 years of age
  • Meet the Classification Criteria of the chronic LBP (having low back pain for more than 6 months)
  • At least 4/10 clinical pain on the 0-10 LBP NRS
  • At least a 10th grade English-reading level; English can be a second language provided that the patients understand all questions used in the assessment measures
  • Meeting the MRI / MEG / EEG screening criteria

Exclusion Criteria12

  • Specific causes of back pain (eg, cancer, fractures, spinal stenosis, infections)
  • Complicated back problems (eg, prior back surgery, medicolegal issues)
  • The intent to undergo surgery during the time of involvement in the study
  • History of cardiac, respiratory, or nervous system disease that, in the investigator's judgment, precludes participation in the study because of a heightened potential for adverse outcome (for example: asthma or claustrophobia)
  • Presence of any contraindications to MRI scanning (for example: cardiac pacemaker, metal implants, claustrophobia, pregnancy, cannot lie still in fMRI scanner)
  • Concomitant autoimmune, chronic, inflammatory, neoplastic, and psychiatric diseases
  • Pregnant or lactating
  • Conditions making study participation difficult (e.g., paralysis, psychoses, or other severe psychological problems as per the judgment of a study investigator during Session 1)
  • Active substance abuse disorders (based on subject self-report and drug test)
  • Regular use of pain medication such as opioids, nonopioid analgesics, coanalgesics, corticosteroids, or immunomodulatory agents
  • Any medical conditions, such as peripheral neuropathy, that could affect the results of QST
  • Current use of psychotropic medication

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEReal tACS

α-tACS at a frequency of alpha band at S1

DEVICESham tACS

Sham tACS with no stimulation applied


Locations(1)

Massachusetts General Hospital

Charlestown, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06568198


Related Trials